310 participants
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-24
- Start Date:
- 2017-02-02
- Completion:
- 2021-09-03
Conditions
- Chronic Lymphocytic Leukemia
Interventions
- DRUG